Trademark: 88776812
Status Date
Friday, June 11, 2021
Filing Date
Wednesday, January 29, 2020
Published for Opposition
Tuesday, November 24, 2020
Abandoned Date
Friday, June 11, 2021
5 Pharmaceutical preparations for human use for the treatment of immunological diseases and disorders, inflammatory diseases and disorders including giant cell arteritis (GCA), oncological diseases and disorders and viral infections, as well as treatment of CAR T-cell induced cytokine release syndrome
Jun 11, 2021
Abandonment Notice E-Mailed - Inter Partes Decision
Jun 11, 2021
Abandonment - After Inter Partes Decision
Jun 11, 2021
Opposition Terminated No. 999999
Jun 11, 2021
Opposition Dismissed No. 999999
May 24, 2021
Opposition Instituted No. 999999
Nov 25, 2020
Extension Of Time To Oppose Received
Nov 24, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 24, 2020
Published For Opposition
Nov 4, 2020
Notification Of Notice Of Publication E-Mailed
Oct 19, 2020
Approved For Pub - Principal Register
Oct 19, 2020
Examiner's Amendment Entered
Oct 19, 2020
Notification Of Examiners Amendment E-Mailed
Oct 19, 2020
Examiners Amendment E-Mailed
Oct 19, 2020
Examiners Amendment -Written
Sep 18, 2020
Previous Allowance Count Withdrawn
Sep 18, 2020
Withdrawn From Pub - Examining Attorney Request
Sep 18, 2020
Attorney Review Completed
Sep 18, 2020
Letter Of Protest Evidence Reviewed-No Further Action Taken
Sep 18, 2020
Letter Of Protest Evidence Forwarded
Jul 21, 2020
Assigned To Lie
Jul 19, 2020
Approved For Pub - Principal Register
Jul 19, 2020
Teas/Email Correspondence Entered
Jul 19, 2020
Correspondence Received In Law Office
Jul 13, 2020
Teas Response To Office Action Received
Apr 20, 2020
Notification Of Non-Final Action E-Mailed
Apr 20, 2020
Non-Final Action E-Mailed
Apr 20, 2020
Non-Final Action Written
Apr 18, 2020
Assigned To Examiner
Feb 4, 2020
New Application Office Supplied Data Entered In Tram
Feb 1, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
